Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amid Swine Flu Hype, Seasonal Flu Vaccinations Are Off To Swift Start

Executive Summary

Most of the public interest and media attention around influenza this year is on the H1N1 virus, or swine flu, and the development of a vaccine to prevent it. But the increased emphasis on flu, in general, is also having implications for seasonal influenza vaccine demand

You may also be interested in...

H1N1 Vaccines Get Green Light In U.S., But Is Anything Else Needed?

Here comes the swine flu again, but this time tens of millions of people could be immunized thanks to the first round of vaccines due in mid-October

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts